# EDGAR Filing Document

**Accession Number:** 0001848334
**File Stem:** 0001209191-23-002472
**Filing Date:** 2023-1
**Character Count:** 9530
**Document Hash:** 6563ded6ac61d17645a779e00340de4f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-002472.hdr.sgml**: 20230106

**ACCESSION NUMBER**: 0001209191-23-002472

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221108

**FILED AS OF DATE**: 20230106

**DATE AS OF CHANGE**: 20230106

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Mansano Roy
- **CENTRAL INDEX KEY:** 0001954059

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56381
- **FILM NUMBER:** 23516225

**MAIL ADDRESS:**
- **STREET 1:** 5343 OSTROM AVE.
- **CITY:** ENCINO
- **STATE:** CA
- **ZIP:** 91316
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OKMIN RESOURCES, INC.
- **CENTRAL INDEX KEY:** 0001848334
- **STANDARD INDUSTRIAL CLASSIFICATION:** CRUDE PETROLEUM & NATURAL GAS [1311]
- **IRS NUMBER:** 854401166
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 16501 VENTURA BLVD.
- **STREET 2:** SUITE 400
- **CITY:** ENCINO
- **STATE:** CA
- **ZIP:** 91436
- **BUSINESS PHONE:** 818-201-3727

**MAIL ADDRESS:**
- **STREET 1:** 16501 VENTURA BLVD.
- **STREET 2:** SUITE 400
- **CITY:** ENCINO
- **STATE:** CA
- **ZIP:** 91436

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Mansano Roy<br><sub>(Last) (First) (Middle)</sub><br>5343 OSTROM AVE.<br><sub>(Street)</sub><br>ENCINO, CA 91316<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2022-11-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>OKMIN RESOURCES, INC. [ OKMN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 3000000 | D |  |
| Common Stock |  |  |  |  |  |  |  | 1250000 | I | By Roy Mansano MD APMC |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 10% Convertible Loan | $0.03 | 2022-11-08 |  | J<sup>(1)</sup> |  |  |  | 2022-11-08 | 2025-05-08 | Common Stock | 56288<sup>(2)</sup> | $0.00 |  | I | By Roy Mansano MD APMC |
| Warrants | <sup>(3)</sup> | 2022-11-08 |  | J<sup>(3)</sup> |  | 18762 |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 18762 | $0.00 | 2497333 | I | By Roy Mansano MD APMC |
| 10% Convertible Loan | $0.03 | 2022-11-08 |  | J<sup>(4)</sup> |  |  |  | 2021-11-17 | 2025-05-08 | Common Stock | 116667<sup>(5)</sup> | $0.00 |  | I | By Roy Mansano MD APMC |
| Warrants | <sup>(6)</sup> | 2022-11-08 |  | J<sup>(6)</sup> |  |  | 38889 | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 38889 | $0.00 | 2458444 | I | By Roy Mansano MD APMC |
| 10% Convertible Loan | $0.03 | 2022-12-08 |  | J<sup>(1)</sup> |  |  |  | 2022-12-08 | 2025-05-08 | Common Stock | 55315<sup>(7)</sup> | $0.00 |  | I | By Roy Mansano MD APMC |
| Warrants | <sup>(3)</sup> | 2022-12-08 |  | J<sup>(3)</sup> |  | 18439 |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 18439 | $0.00 | 2476883 | I | By Roy Mansano MD APMC |
| 10% Convertible Loan | $0.03 | 2022-12-08 |  | J<sup>(4)</sup> |  |  |  | 2021-11-17 | 2025-05-08 | Common Stock | 116666<sup>(8)</sup> | $0.00 |  | I | By Roy Mansano MD APMC |
| Warrants | <sup>(6)</sup> | 2022-12-08 |  | J<sup>(6)</sup> |  |  | 38889 | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 38889 | $0.00 | 2437994 | I | By Roy Mansano MD APMC |
| 10% Convertible Loan | $0.03 | 2023-01-03 |  | J<sup>(9)</sup> |  |  |  | 2021-11-17 | 2025-05-08 | Common Stock | 1517101<sup>(10)</sup> | $0.00 | 173906.46 | I | By Roy Mansano MD APMC |
| Warrants | <sup>(9)</sup> | 2023-01-03 |  | J<sup>(9)</sup> |  |  | 505700 | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 505700 | $0.00 | 1932294 | I | By Roy Mansano MD APMC |

---

### Footnotes:

(1) Represents interest accrued on the 10% Convertible Loan (the "Loan") on this date. The outstanding principal and accrued interest on the Loan (the "Loan Amount") is convertible at any time into shares of Common Stock at a conversion price of $0.03 per share. For every three shares of Common Stock received upon conversion of the Loan Amount, the holder will also receive one Warrant to buy an additional share of Common Stock at an exercise price of $0.03 per share. The Warrants underlying the Loan Amount are also reported on this form.

(2) The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,492,001.

(3) These Warrants are not currently outstanding but may be issued upon conversion of the interest that was accrued on the Loan on this date. The Warrants will be exercisable immediately if and when issued and will have an exercise price of $0.03 per share and a three-year term.

(4) Represents a Loan payment on this date, which reduced the Loan Amount by the amount of the payment.

(5) The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,375,334.

(6) These Warrants were subject to issuance upon conversion of the Loan Amount that was paid on this date. The Warrants would have been exercisable immediately if and when issued and would have had an exercise price of $0.03 per share and a three-year term.

(7) The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,430,649.

(8) The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,313,983.

(9) On January 3, 2023, the terms of the Loan were amended to provide that at no time shall the reporting person be permitted to convert any portion of the Loan Amount if such conversion would result in his being the beneficial owner of more than 9.99% of the issuer's class of Common Stock. The amendment had the effect of reducing the reporting person's beneficial ownership on this date to below 9.99% as indicated.

(10) The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 5,796,882.

**Signature:** /s/ Roy Mansano  
**Date:** 2023-01-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**